China Healthwise Holdings Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was HKD 76.27 million compared to HKD 97.9 million a year ago. Net loss was HKD 15.18 million compared to net income of HKD 36.57 million a year ago.

Basic loss per share from continuing operations was HKD 0.0197 compared to basic earnings per share from continuing operations of HKD 0.0475 a year ago. Diluted loss per share from continuing operations was HKD 0.0197 compared to diluted earnings per share from continuing operations of HKD 0.0453 a year ago.